Biomerica, Inc.
BMRA
$2.80
$0.041.45%
NASDAQ
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.31M | 5.68M | 5.58M | 5.51M | 5.41M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.31M | 5.68M | 5.58M | 5.51M | 5.41M |
| Cost of Revenue | 4.81M | 4.91M | 4.98M | 5.02M | 4.81M |
| Gross Profit | 501.00K | 765.00K | 597.00K | 485.00K | 608.00K |
| SG&A Expenses | 4.61M | 4.83M | 5.32M | 5.67M | 5.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.45M | 10.78M | 11.47M | 12.01M | 11.78M |
| Operating Income | -5.14M | -5.10M | -5.89M | -6.50M | -6.37M |
| Income Before Tax | -4.97M | -4.85M | -5.59M | -6.14M | -5.94M |
| Income Tax Expenses | 2.00K | 4.00K | 12.00K | 23.00K | 42.00K |
| Earnings from Continuing Operations | -4.97 | -4.85 | -5.61 | -6.16 | -5.98 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.97M | -4.85M | -5.61M | -6.16M | -5.98M |
| EBIT | -5.14M | -5.10M | -5.89M | -6.50M | -6.37M |
| EBITDA | -5.05M | -5.01M | -5.80M | -6.42M | -6.29M |
| EPS Basic | -2.25 | -2.23 | -2.66 | -2.93 | -2.84 |
| Normalized Basic EPS | -1.41 | -1.39 | -1.66 | -1.82 | -1.76 |
| EPS Diluted | -2.33 | -2.28 | -2.71 | -2.95 | -2.87 |
| Normalized Diluted EPS | -1.41 | -1.39 | -1.66 | -1.82 | -1.76 |
| Average Basic Shares Outstanding | 8.85M | 8.75M | 8.45M | 8.41M | 8.41M |
| Average Diluted Shares Outstanding | 8.85M | 8.75M | 8.45M | 8.41M | 8.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |